Research Projects

Development of HLA-independent T cells redirected by nanoantibodies as a new therapeutic strategy for multiple myeloma. HINT4MM

Dr. Juan Roberto Rodríguez Madoz Curriculum

Researcher Immune Therapies Research Group

Research Division

Cancer Division

Research program

Hemato-Oncology

Research group

Immune Therapies

Project information

“Development of HLA-independent T cells redirected by nanoantibodies as a new therapeutic strategy for multiple myeloma. HINT4MM” is a project carried out by the Immune Therapies research group, which forms part of the Haematology-Oncology programme.

Project PID2025-173188OB-I00 funded by:

Convocation: Proyectos de Generación de Conocimiento 2025
Reference: PID2025-173188OB-I00
Start date: September 1, 2026
End date: August 31, 2029
Nature of project: National

Need more information?

If you are interested in learning more about our research, please contact us.

GO TO ALL CIMA RESEARCH PROJECTS